Article Details

RNAi biotech Atalanta debuts with $110m plus Biogen and Roche CNS tie-ups

Retrieved on: 2021-01-12 09:22:30

Tags for this article:

Click the tags to see associated articles and topics

RNAi biotech Atalanta debuts with $110m plus Biogen and Roche CNS tie-ups. View article details on hiswai:

Excerpt

The founders formed the company with backing from investor F-Prime Capital and has just launched its Series A round with Roche's Genentech unit ...

Article found on: pharmaphorum.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up